HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis.

AbstractOBJECTIVE:
To compare the HLA-DRB1 shared epitope (SE) alleles in Japanese patients with rheumatoid arthritis (RA) and amyloid A (AA) amyloidosis versus those without AA amyloidosis.
METHODS:
The HLA-DRB1 alleles were genotyped for 91 RA patients without AA amyloidosis, 33 RA patients with AA amyloidosis, and 63 control subjects. HLA-DRB1 typing was performed by polymerase chain reaction, sequence-specific oligonucleotide probe hybridization method.
RESULTS:
Although a significant difference was not observed, the frequency of SE genotype was higher in RA patients with AA amyloidosis than in those without AA amyloidosis. All SE-positive RA patients with AA amyloidosis had *04 alleles (*0401, *0405, *0410), and a significant association of the presence of a double dose of *04 SE alleles with AA amyloidosis (OR 4.0, 95% CI 1.91-13.99) was observed.
CONCLUSION:
Our data suggest that presence of double *04 SE is associated with a higher risk of developing AA amyloidosis in Japanese patients with RA.
AuthorsKiyoshi Migita, Tadashi Nakamura, Yumi Maeda, Taichiro Miyashita, Tomoki Origuchi, Hiroshi Yatsuhashi, Minoru Nakamura, Hiromi Ishibashi, Katsumi Eguchi
JournalThe Journal of rheumatology (J Rheumatol) Vol. 33 Issue 11 Pg. 2120-3 (Nov 2006) ISSN: 0315-162X [Print] Canada
PMID17086601 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • Serum Amyloid A Protein
Topics
  • Aged
  • Amyloidosis (ethnology, etiology, genetics)
  • Arthritis, Rheumatoid (complications, ethnology, genetics)
  • Asian People
  • Case-Control Studies
  • Epitopes (genetics, immunology)
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • HLA-DR Antigens (genetics, immunology)
  • HLA-DRB1 Chains
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Serum Amyloid A Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: